Durable response after just one cycle of belotecan-based chemotherapy in a patient with relapsed primary peritoneal serous carcinoma.
Autor: | Lee GJ; Department of Internal Medicine, Bucheon St Mary's Hospital, The Catholic University School of Medicine, Bucheon, Korea., Min JW, Seo MW, Lee MY, Jin JY |
---|---|
Jazyk: | angličtina |
Zdroj: | The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2014 Jan; Vol. 40 (1), pp. 297-300. Date of Electronic Publication: 2013 Sep 19. |
DOI: | 10.1111/jog.12161 |
Abstrakt: | The efficacy of second-line chemotherapy for relapsed primary peritoneal serous carcinoma has been numerously reported, but reports on durable response after second-line therapy have been rare. We report the case of a 66-year-old woman with relapsed primary peritoneal serous carcinoma who showed durable response after just one cycle of second-line belotecan-based therapy. The response might be a complete pathologic remission. Considering the fact that our patient suffered from neutropenic sepsis during her treatment, we concluded that belotecan-based chemotherapy could be a good option for second-line chemotherapy in some selected patients, so patient selection should be carefully performed due to the toxicity of belotecan. (© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.) |
Databáze: | MEDLINE |
Externí odkaz: |